Literature DB >> 27650831

The Tromsø study 1974-2016: 40 years of cardiovascular research.

Inger Njølstad1, Ellisiv B Mathiesen2,3, Henrik Schirmer2,4, Dag Steinar Thelle5,6.   

Abstract

The rapid increase of coronary heart disease mortality in Northern Norway during 1951-1970 was why the newly established University of Tromsø decided to start a study to identify major operating cardiovascular risk factors. The first Tromsø survey in 1974 suggested that the relatively high cardiovascular mortality was associated with elevated cholesterol levels and high prevalence of smoking, while high-density-lipoprotein-cholesterol (HDL-C) was identified as a preventive factor. After 1974, six more surveys including both genders (aged 20-89 years) were undertaken. The second survey (1979) revealed the cholesterol increasing effect of coffee. Echocardiographic examinations, ECG, and ultrasound of carotid arteries were introduced in later surveys, and intervention studies were established. Repeated carotid measurements showed that inflammation was involved in novel plaque formation, while HDL-C was protective. Moderate physical activity protected against atrial fibrillation but hard exercise increased the risk. Obesity, hypertension and smoking increased the risk of aortic stenosis, and diastolic dysfunction predicted development of atrial fibrillation. Dilated left atria predicted stroke, especially for individuals without known atrial fibrillation. Total cholesterol, blood pressure and smoking declined after 1974, corresponding to the subsequent decline in coronary heart disease mortality. Reduced incidence accounted for 40% of the mortality decline, while a substantial reduction in case fatality explained the remaining 60%.

Entities:  

Keywords:  Tromsø; cardiovascular epidemiology; coronary risk factor changes; four decades of research activity; incidence and mortality

Mesh:

Substances:

Year:  2016        PMID: 27650831     DOI: 10.1080/14017431.2016.1239837

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  6 in total

1.  Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population-Based Tromsø Study.

Authors:  Jocasta Ball; Maja-Lisa Løchen; Tom Wilsgaard; Henrik Schirmer; Laila A Hopstock; Bente Morseth; Ellisiv B Mathiesen; Inger Njølstad; Sweta Tiwari; Ekaterina Sharashova
Journal:  J Am Heart Assoc       Date:  2018-04-19       Impact factor: 5.501

2.  Survival to Age 90 in Men: The Tromsø Study 1974-2018.

Authors:  Tormod Brenn
Journal:  Int J Environ Res Public Health       Date:  2019-06-06       Impact factor: 3.390

3.  Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994-2016.

Authors:  Petja Lyn Langholz; Tom Wilsgaard; Inger Njølstad; Rolf Jorde; Laila Arnesdatter Hopstock
Journal:  BMJ Open       Date:  2021-03-23       Impact factor: 2.692

4.  Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study.

Authors:  Torunn Varmdal; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Audhild Nyrnes; Sameline Grimsgaard; Kaare Harald Bønaa; Jan Mannsverk; Maja-Lisa Løchen
Journal:  Clin Epidemiol       Date:  2021-08-03       Impact factor: 4.790

5.  The seventh survey of the Tromsø Study (Tromsø7) 2015-2016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey.

Authors:  Laila A Hopstock; Sameline Grimsgaard; Heidi Johansen; Kristin Kanstad; Tom Wilsgaard; Anne Elise Eggen
Journal:  Scand J Public Health       Date:  2022-05-04       Impact factor: 3.199

6.  Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015-2016.

Authors:  Jonas Johansson; Bjørn Heine Strand; Bente Morseth; Laila Arnesdatter Hopstock; Sameline Grimsgaard
Journal:  BMC Geriatr       Date:  2020-11-10       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.